Healthcare Triangle, Inc.
No enriched coverage for $HCTI in the last 7 days.
No SEC Form 4 filings for $HCTI in the last 30 days.
See all $HCTI insider activity →Nasdaq notified Healthcare Triangle (HCTI) of a delisting due to noncompliance with the $1.00 minimum bid price rule and prior reverse splits. The company plans to appeal, which would stay the suspension and allow continued trading under HCTI.
Healthcare Triangle (HCTI) signed an MOU with AI World to form a joint venture for AI-enabled humanoid nursing robots in North America. HCTI will hold 70% ownership, leveraging its hospital network. The robots aim to assist with patient hygiene, addressing nursing shortages. The global market for robotic nurse assistants is projected to reach $4.4B by 2033. The venture is subject to due diligence and regulatory approvals.
Healthcare Triangle, Inc. (HCTI) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. Item 1.01 Entry into a Material Definitive Agreement. On September 22, 2026, Healthcare Triangle, Inc. (“HCTI” or the “Company”), a Delaware corporation, entered into the First Amendment to the Equity Purchase Agreement (the “Amendment”), which amends the Equity Purchase Agreemen
Recent HCTI coverage spans corporate actions, financial news and mergers & acquisitions.
Potential suspension and delisting pressure on HCTI shares.
The announcement could lift HCTI if the venture proceeds, but the non‑binding nature and execution risks keep impact uncertain.
Amendment may limit future equity dilution and set a higher floor price, potentially supporting share price.
The acquisition could diversify HCTI beyond healthcare into industrial automation, potentially boosting long‑term growth but also adding integration risk.
The partnership positions HCTI as a bridge for Malaysian health‑tech firms to access U.S. capital, potentially expanding HCTI's advisory revenue and market visibility.
AlphAI scores every news story that mentions HCTI with an AI model for sentiment and relevance, and aggregates insider trades from Healthcare Triangle, Inc.'s SEC EDGAR Form 4 filings. Figures refresh continuously.
Nasdaq notified Healthcare Triangle (HCTI) of a delisting due to noncompliance with the $1.00 minimum bid price rule and prior reverse splits. The company plans to appeal, which would stay the suspension and allow continued trading under HCTI.
1 min readHealthcare Triangle (HCTI) signed an MOU with AI World to form a joint venture for AI-enabled humanoid nursing robots in North America. HCTI will hold 70% ownership, leveraging its hospital network. The robots aim to assist with patient hygiene, addressing nursing shortages. The global market for robotic nurse assistants is projected to reach $4.4B by 2033. The venture is subject to due diligence and regulatory approvals.
2 min readHealthcare Triangle, Inc. (HCTI) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. Item 1.01 Entry into a Material Definitive Agreement. On September 22, 2026, Healthcare Triangle, Inc. (“HCTI” or the “Company”), a Delaware corporation, entered into the First Amendment to the Equity Purchase Agreement (the “Amendment”), which amends the Equity Purchase Agreemen
1 min readHealthcare Triangle (HCTI) signed a non-binding LOI to acquire Roboticom's industrial robotics business. Roboticom's 2025 revenue was $14.1M, with projections of $153.5M by 2029/30. HCTI may pay up to $30M in cash and equity. The deal aims to expand HCTI's tech platform into industrial automation.
2 min readHealthcare Triangle (HCTI) partners with Kanzun-ARCB Growth Fund to help Malaysian healthcare companies expand into U.S. markets. HCTI will provide AI, cloud, and data expertise. ARCB brings AED 300M in assets, while Kanzun leads deal sourcing in Malaysia.
2 min readHealthcare Triangle, Inc. (HCTI) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. Item 1.01 Entry into a Material Definitive Agreement. On September 2, 2026, Healthcare Triangle, Inc. (“HCTI” or the “Company”), a Delaware corporation, entered into (i) a Separation and Distribution Agreement (the “Separation Agreement”) and (ii) a Transition Services Agreement
2 min readHealthcare Triangle, Inc. (Nasdaq: HCTI) reported Q2 2026 revenue of $9.19M, up 158% year over year, and gross profit of $2.07M, up 322%. The AI platform contributed about 69% of revenue and gross margin rose to 22.5% from 13.8%. The Teyame and Datono acquisition contributed $6.31M revenue. Stockholders’ equity rose to $49.1M from $9.9M.
4 min readHealthcare Triangle (Nasdaq: HCTI) said it signed a non-binding LOI to acquire a 51% stake in CosmoInnovations (CosmoAesthetics Pty Ltd). Proposed consideration is $23.5 million over three years via cash, equity, and performance milestones. The deal would add 27 granted international patents and 61 pending applications, targeting over $50 million cumulative revenue in three years.
4 min readHealthcare Triangle, Inc. (Nasdaq: HCTI) said it completed on July 24, 2026 the issuance of 12,546,540 common shares tied to its Teyame AI LLC acquisition and a SecureKloud Technologies Ltd. share exchange. Shares outstanding rose to 14,644,322. The company cited Nasdaq’s new $5 million MVLS continued listing standard, estimating MVLS of about $23.87 million as of July 28, 2026.
4 min readHealthcare Triangle, Inc. (HCTI) filed an SEC Form 8-K — Unregistered Sales of Equity Securities. Exhibit 99.1 Healthcare Triangle Completes Share Issuances Relating to Legacy M&A Transactions, Strengthening Compliance With Nasdaq’s New $5 Million Market Value Listing Standard Common shares outstanding increase to 14,644,322 following the closing of two previously approved tr
2 min read
